Recruiting

Observational Study

Sponsor:

National Eye Institute (NEI)

Code:

NCT02617966

Conditions

Retinal Degeneration

Retinitis Pigmentosa

Stargardt's Disease

Eligibility Criteria

Sex: All

Age: 5 - 70+

Healthy Volunteers: Accepted

Study Details

Brief summary:

Background:

Retinal diseases cause the loss of rod and cone photoreceptors. Symptoms include vision loss and night blindness. Researchers want to learn about rod and cone function in healthy people and people with retinal disease. They want to know if how well a person sees in the dark can test the severity of retinal disease.

Objectives:

To find out if how well a person sees in the dark can test the severity of retinal disease. To find out if this can help detect retinal disease and track its changes.

Eligibility:

People ages 5 and older with:

Retinal disease OR

20/20 vision or better with or without correction in at least one eye

Design:

Participants will be screened with medical and eye history and eye exam. Those with retinal disease will also have:

Eye imaging: Drops dilate the eye and pictures are taken of it.

Visual field testing: Participants look into a bowl and press a button when they see light.

Electroretinogram (ERG): An electrode is taped to the forehead. Participants sit in the

dark with their eyes patched for 30 minutes. Then they get numbing drops and contact

lenses. Participants watch lights while retina signals are recorded.

Visit 1 will be 3-8 hours. Participants will have up to 6 more visits over 6-12 months. Visits include:

Eye exam and imaging

Time course of dark adaptation: Participants view a background light for 5 minutes then

push a button when they see colored light.

Dark adapted sensitivity: Participants sit in the dark for 45 minutes. They push a button when

they see colored light.

For participants with retinal disease, ERG and visual field testing

Conditions

Retinal Degeneration

Retinitis Pigmentosa

Stargardt's Disease

Study ID

NCT02617966

Start date

Mar 24, 2016

Status verified date

Aug 18, 2026

Completion date

Dec 30, 2029

Anticipated

Primary completion date

Dec 30, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 5 - 70+

Healthy Volunteers: Accepted

  • INCLUSION CRITERIA:
  • Participant must be five years of age or older.
  • Participant (or legal guardian) must understand and sign the protocol s informed consent document.
  • Participant must be able to cooperate with the testing required for this study.

For Participants with retinal disease only:

  • Participant must have retinal disease, defined as evidence of loss of retinal dysfunction and/or degeneration as established by standard clinical methods including perimetry, ERG and imaging.
  • Participant must have a measurable visual acuity.

For Healthy Volunteers only:

-Participant must have visual acuity of 20/20 or better, with or without correction (e.g., glasses or contact lens) in at least one eye.

EXCLUSION CRITERIA:

-Participant with changes in pre-retinal media sufficient to obscure a view of the retina.

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Arms

Affected

Participants with retinal disease

Unaffected

Healthy volunteers

Primary outcome measure

  • The primary outcomes for this study are to establish normal ranges for the kinetics of dark adaptation and dark-adapted retinal sensitivity for the fundus guided and non-guided perimeters and for RF hyperacuity on the Display++. [ Time Frame: ongoing, up to 10 visits in 5 years ]

Central Contacts and Locations

Central contacts

Locations

National Institutes of Health Clinical Center

Recruiting

Bethesda, Maryland, United States, 20892

More Information

Sponsor

National Eye Institute (NEI)

Last update posted

Aug 31, 2026

Last verified

Aug 18, 2026

Keywords

  • Retina
  • Retinal Degeneration
  • Retinitis Pigmentosa
  • Stargardt's Disease
  • Dark Adaptation

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-07. This information was provided to ClinicalTrials.gov by National Eye Institute (NEI) on 2026-08-31. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.